Brian Kearney - 14 Sep 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC.

Role
Chief Development Officer
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Sep 2022
Net transactions value
$0
Form type
4
Filing time
16 Sep 2022, 16:14:01 UTC
Previous filing
02 Feb 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 14 Sep 2022 Common Stock 125,000 $2.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest over two years with 1/2 of the shares subject to such option vesting and becoming exercisable on September 14, 2023, and the remaining 1/2 of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 14th day of each month thereafter, subject to continued service relationship.